Survey for NPs Who Treat Type 2 Diabetes
Are you a nurse practitioner who treats Type 2 diabetes mellitus (T2DM)? If so, AANP is seeking your insight to help identify clinical challenges. Your response to a quick 10 minute survey will guide AANP in the development of a new T2DM CE activity that will target the learning needs of NPs working in this therapeutic area. After the CE activity is developed, it will be available on the AANP CE Center at no cost. Participation in the survey is available for a limited time, so let your voice be heard! Respond today. Thank you for your time and input.
Interactive T2DM Newsletter with Free CE
AANP has launched an interactive T2DM newsletter, Incretin-Based Therapies in the Management of T2DM (0.75 CE which includes 0.75 pharmacology credit). The goal of this activity is to assist primary care clinicians in addressing glycemic variability in patients with T2DM, with a focus on the optimal use of GLP-1 receptor agonists and DPP-4 inhibitors in individualized treatment regimens. This case based learning activity is offered at no cost to members and non-members. The program was developed by the New Jersey Academy of Family Physicians (NJAFP), the American Association of Nurse Practitioners (AANP), and the American Academy of Physician Assistants (AAPA) in cooperation with MCM Education and supported by an educational grant from Novo Nordisk Inc. To access this program, please visit the AANP CE Center.
New Diabetes Management CE
AANP has launched a new learning activity, Getting Type 2 Diabetes Mellitus Patients to Goal: The Role of New and Emerging Injectable Therapies (1.0 CE, which includes 1.0 pharmacology credit). This case-based learning activity reviews the newest injectable therapies including basal analogs and GLP1s, while identifying best practices for selecting, initiating and advancing appropriate injectable therapies in the treatment of T2DM. The program is geared toward primary care nurse practitioners and is offered at no cost to members and non-members due to an educational grant from Novo Nordisk Inc.
Obesity Management CE
Treatment and management of obesity is complex, and therefore, it is important for nurse practitioners to individualize treatment plans and incorporate evidenced based strategies into their practice. How to Talk to Your Patients about Obesity: A Dialogue about Obesity Management (1.2 CE with 0.50 pharmacology) is a case-based learning activity demonstrating ways to improve clinician/patient engagement, communication, assessment and management of obesity. The program is geared toward nurse practitioners and is offered at no cost to members and non-members. Funding was provided by an educational grant from Novo Nordisk Inc. and Takeda Pharmaceuticals U.S.A., Inc.